| Patient | Voltaire |
|---|---|
| Date of birth | 1694-11-21 |
| Identifiers | MRN HR-EN002-SYN-TD; SSN (made up) 000-02-5174 |
| Document date | 1778-04-28 |
| Author | Honorine Delacroix-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subsequent annual wellness visit, a week after the bladder cancer diagnosis. [S]
Voltaire returns for his subsequent annual wellness visit, six days after he learned that the bladder tumor is a muscle-invasive squamous cell carcinoma and chose weekly radiotherapy. The planning scan was done yesterday and the first treatment is tomorrow. His fever settled within two days of starting cefpodoxime, and he finished the seven-day course two days ago; the culture grew Escherichia coli sensitive to it. He has voided without a catheter for six days, getting up twice at night. He takes acetaminophen three times a day and has used two half tablets of oxycodone in six days, for bladder spasm in the evening; he keeps them in a locked box. He completed the health risk assessment beforehand. He has had no falls. He has cut his coffee to three cups a day and sleeps about five hours without the sleep aid. He is still at work on his play. [S]
| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit, age 83 |
| Active conditions | Muscle-invasive squamous cell carcinoma of the bladder before radiotherapy; chronic retention, voiding; enlarged prostate; chronic constipation |
| Medicines | Tamsulosin, polyethylene glycol, senna, acetaminophen, oxycodone 2.5 mg as needed (two doses in six days), naloxone; cefpodoxime course completed two days ago |
| Safety events | No falls; one sick visit for the catheter infection; no hospital admission |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Fair; "better than my physicians expected, worse than I would like" |
| Psychosocial | Many visitors and friends; a live-in assistant; no money worries; low mood on some days since the diagnosis, without hopelessness |
| Behavioral | Never smoker; one glass of wine with dinner (AUDIT-C 2); coffee down to three cups a day; walks indoors and short distances outside |
| Activities of daily living | Independent in bathing, dressing, eating, toileting, and transfers |
| Instrumental activities of daily living | Manages his own medicines and correspondence; needs help with shopping, travel, and housework |
| Home safety | Smoke detectors working; night light on the way to the toilet added this week; no loose rugs |
| Hearing and vision | Hears well in conversation; reading glasses; eye examination last year |
| Bladder and bowel | Voids every two to three hours by day and twice at night; bowels open every one to two days on polyethylene glycol and senna |
| Memory | No concerns; still writing and directing rehearsals |
| Nutrition | Small appetite; weight 53.5 kg, down 0.7 kg in three weeks |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tires easily; weight down 0.7 kg; no fever for six days |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No nosebleeds since the episode in late winter |
| Cardiovascular | Negative | No chest pain or palpitations; no dizziness on standing |
| Respiratory | Negative | No cough, blood in the sputum, or breathlessness |
| Gastrointestinal | Negative | Bowels regular on the current regimen; no blood or pain |
| Genitourinary | Positive | Frequency and nocturia twice; urine pale pink at times; occasional evening bladder spasm |
| Musculoskeletal | Negative | No bone pain or falls |
| Integumentary | Negative | No rash; smallpox scars only |
| Neurological | Negative | No weakness, numbness, or memory change |
| Psychiatric | Positive | Low on some days since the diagnosis; PHQ-2 score 1; sleeps about five hours |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Diphenhydramine 25 mg oral capsule, one capsule at night for sleep (over the counter) | One capsule at bedtime | Oral route | 1777-09-01 to 1778-04-06 | stopped | S |
| Tamsulosin 0.4 mg oral capsule, one capsule at bedtime | One capsule 30 minutes after the evening meal | Oral route | 1778-04-06 | active | S |
| Polyethylene glycol 3350, 17 g in a glass of water once daily | 17 g dissolved in water once daily | Oral route | 1776-01-15 | active | S |
| Cefpodoxime 200 mg oral tablet, one tablet by mouth twice daily for 7 days | One tablet twice daily with food for 7 days | Oral route | 1778-04-20 to 1778-04-26 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth three times daily (3 g a day) | Two tablets three times daily; no more than 3 g a day | Oral route | 1778-04-22 | active | S |
| Oxycodone 5 mg oral tablet, one half tablet (2.5 mg) by mouth every 6 hours if needed for bladder pain not relieved by acetaminophen, no more than three doses a day; 15 tablets dispensed | Half a tablet every 6 hours as needed; no more than three half tablets a day | Oral route | 1778-04-22 | active | S |
| Sennosides 8.6 mg oral tablet, two tablets at bedtime while taking oxycodone | Two tablets at bedtime | Oral route | 1778-04-22 | active | S |
| Naloxone 4 mg nasal spray, one spray in one nostril for suspected opioid overdose; call 911; may repeat in 2 to 3 minutes in the other nostril | One spray for suspected overdose; repeat after 2 to 3 minutes if no response | Nasal route | 1778-04-22 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1778-04-28 | Body height | 170 | cm | S |
| 1778-04-28 | Body weight | 53.5 | kg | S |
| 1778-04-28 | Body mass index (BMI) [Ratio] | 18.5 | kg/m2 | S |
| 1778-04-28 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1778-04-28 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1778-04-28 | Heart rate | 78 | /min | S |
| 1778-04-28 | Respiratory rate | 16 | /min | S |
| 1778-04-28 | Body temperature | 36.6 | Cel | S |
| 1778-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1778-04-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1778-04-28 | Total score [Mini-Cog] | 4 | {score} | S |
Vital signs recorded on 1778-04-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Thin (BMI 18.5), alert, and quick; blood pressure 126/70 mmHg seated and 120/68 mmHg standing |
| Eyes | Near vision 20/40 with reading glasses |
| Ears | Whispered-voice test passed on both sides |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Abdomen | Soft; mild suprapubic tenderness; bladder not palpable |
| Musculoskeletal | Timed Up and Go 13 seconds with his stick; rises from a chair using his arms |
| Neurological | Oriented; Mini-Cog 4 of 5 (recall 2 of 3, clock normal) |
| Psychiatric | Wry and engaged; mood "steady, mostly"; no hopelessness |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Visible blood in the urine for three weeks with clots, and a weak stream, straining, and frequent small voids, in a man of 83; under evaluation | resolved | confirmed | R31.0 | S — Synthetic presenting problem echoing his documented urinary complaints and last illness; superseded by the diagnosis at the third chronic-care visit. |
| Chronic urinary retention with overflow (post-void residual 460 mL at intake), worsened by a nightly anticholinergic sleep aid; drained by an indwelling catheter | active | confirmed | R33.8 | S — Synthetic finding echoing the strangury and catheterization documented in his last weeks. |
| Acute kidney injury from bladder outlet obstruction (creatinine 1.68 mg/dL, from 1.1 mg/dL a year earlier) | resolved | confirmed | N17.9 | S — Synthetic finding; it echoes, without asserting, the later encyclopedia term uremia. |
| Benign prostatic hyperplasia with lower urinary tract symptoms: prostate about 78 mL on CT, enlarged, firm, and smooth on examination, PSA 6.4 ng/mL with a PSA density of 0.08; no prostate biopsy, by shared decision | active | confirmed | N40.1 | S — Synthetic diagnosis echoing the very large prostate described at the 1778 autopsy; whether that prostate was malignant is unknown (CLM-0012). |
| Squamous cell carcinoma of the bladder, keratinizing, posterior wall extending to the dome, muscle-invasive with extravesical extension (clinical stage cT3b N0 M0, stage IIIA), pure squamous histology without a urothelial component; treated with palliative-intent hypofractionated radiotherapy by shared decision | active | confirmed | C67.4 | S — Synthetic modern diagnosis confirmed by resection pathology. His bladder disease at autopsy is documented (D); calling it squamous cell carcinoma is a 2025 retrospective interpretation (R, disputed). |
| Chronic constipation, lifelong by his account, with long use of laxatives and self-given enemas | active | confirmed | K59.09 | S — Synthetic modern problem echoing his documented colic, purges, and enemas; no diagnosis of inflammatory bowel disease is made. |
| Febrile catheter-associated urinary tract infection with Escherichia coli, five days after bladder tumor resection; treated with cefpodoxime and a catheter change; resolved | resolved | confirmed | T83.511A | S — Synthetic intercurrent infection; it echoes, without asserting, the infected urine described in his last weeks (CLM-0009). |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine | Up to date | High-dose vaccine given in the autumn; next due next autumn |
| COVID-19 vaccine | Up to date | Current-season dose received at his pharmacy in the autumn |
| Pneumococcal vaccine | Up to date | PCV20 given; no further doses needed |
| RSV vaccine | Up to date | Single dose given; no repeat recommended |
| Recombinant zoster vaccine | Up to date | Two-dose series completed |
| Tetanus booster | Up to date | Tdap seven years ago; next due in three years |
| Depression screening | Completed today | PHQ-2 score 1; the palliative care team will also follow his mood |
| Alcohol misuse screening | Completed today | AUDIT-C 2; advised no alcohol on days he takes oxycodone |
| Cognitive assessment | Completed today | Mini-Cog 4 of 5 |
| Falls prevention | Referred | Home physical therapy for strength and balance; night light and urinal |
| Nutrition | Completed today | Oral supplement twice a day; weight at each visit |
| Medication review | Completed today | Diphenhydramine and phosphate enemas stopped at intake; no other high-risk medicines; one prescriber for the opioid |
| Colorectal cancer screening | Not indicated | Age 83 with a new cancer; after discussion he declines further screening |
| Prostate cancer screening | Not indicated | USPSTF recommends against PSA screening from 70; his PSA at intake was diagnostic, and no biopsy is planned |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker; past the age range for aneurysm screening; chest CT clear at intake |
| Hearing and vision | Up to date | Whispered-voice test passed; eye examination last year |
Guideline basis: American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Prostate Cancer: Screening (2018); CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); Adult Immunization Schedule by Age (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); Colorectal Cancer: Screening (2021); Abdominal Aortic Aneurysm: Screening (2019); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018)
Follow-up: Radiotherapy starts tomorrow. Chronic-care review in eight days as planned, with blood tests and a bladder scan. Home physical therapy this week. Next annual wellness visit in one year. Next scheduled visit 1778-05-06: two-week review during weekly radiotherapy: symptoms, kidney function, voiding, and opioid safety. [S]
Voluntary advance care planning discussion of about 25 minutes, with his consent, prompted by the cancer diagnosis. He names a long-time younger colleague as his health care agent and signed the state directive form today. He wants treatment that keeps him at home and able to write, including radiotherapy and treatment of infections, and a short hospital stay for a reversible problem such as bleeding or blocked urine. He would not want resuscitation, a breathing machine, or major surgery, and he wants comfort-focused care at home if the cancer progresses. A portable medical order for life-sustaining treatment was completed with these choices (do not attempt resuscitation; selective treatment). He wants frank information and asked that his medicines for pain and sleep be kept simple and prescribed by one clinician. [S]